Compare Charles River Laboratories Intl. Inc (CRL) vs Kinder Morgan Inc (KMI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charles River Laboratories Intl. Inc vs Kinder Morgan Inc — how do they compare? Charles River Laboratories Intl. Inc trades at $299.12 (market cap $14.23B), while Kinder Morgan Inc trades at $32.47 (market cap $71.81B). The key difference: Kinder Morgan Inc is far larger — about 5× Charles River Laboratories Intl. Inc's market cap, and Kinder Morgan Inc pays a 3.66% dividend while Charles River Laboratories Intl. Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Charles River Laboratories Intl. Inc for 33 Days and Kinder Morgan Inc for 150 Days on average.
| CRL | KMI | |
|---|---|---|
Market Cap | $14.23B | $71.81B |
Volume | 1,176,885 | 16,921,908 |
Sector | Health | Energy |
52-Week High | $310.77 | $34.31 |
52-Week Low | $149.93 | $25.84 |
Typical Hold Time | 33 Days | 150 Days |
Enterprise Value | $17.06B | $103.86B |
Dividend Yield | — | 3.66% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Charles River Laboratories (CRL) trades at $300.53, up 0.08% on the day, with a bullish technical outlook and strong analyst support. The stock has consistently beaten earnings estimates in recent quarters, though it faces profitability challenges with a negative net income margin and ROE. Recent investor day presentations highlighted a strategic plan targeting 5-7% revenue growth and $300 million in savings by 2030, driving positive sentiment.
The outlook is cautiously optimistic, supported by analyst buy ratings and a $305.50 consensus price target, but risks include ongoing margin pressure, volatile non-human primate costs, and a high valuation multiple. Earnings growth and successful execution of the new strategic plan are critical for sustained upside.
Kinder Morgan (KMI) trades at $31.82, down 1.06% on the day, with strong technical momentum indicated by bullish moving averages. The company demonstrates robust fundamentals with revenue growth from $15.1B in 2024 to $16.9B in 2025 and net income margins expanding to 19.31%. Recent earnings beats in Q4 2025 through Q2 2026 highlight operational strength, while a $6B-$7B growth pipeline supports future expansion in natural gas infrastructure.
KMI presents a compelling investment case with analyst consensus target of $37.20 offering 17% upside potential. The stock's 4% dividend yield and consistent cash flow generation provide income stability, though exposure to energy market volatility and high debt levels ($29.66B long-term debt) remain key risks. Wall Street sentiment is balanced with 47% buy ratings versus 50% hold recommendations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Charles River Laboratories Intl. Inc
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →About Kinder Morgan Inc
Kinder Morgan is one of the largest midstream energy firms in North America, with an interest in or an operator on about 83,000 miles in pipelines and over 140 storage terminals. The company is active in the transportation, storage, and processing of natural gas, crude oil, refined products, natural gas liquids, and carbon dioxide. The majority of Kinder Morgan's cash flows stem from fee-based contracts for handling, moving, and storing fossil fuel products.
Read more on KMI →
